United States Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Oncology Market, United States, Revenue ($m), 2018-2033
3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 BCR-ABL Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 BRAF Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 BRCA Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.5 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.6 EGFR Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.7 HER2 Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.8 KRAS Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, United States, Volume (Units), 2018-2033
3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 BCR-ABL Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 BRAF Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 BRCA Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.5 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.6 EGFR Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.7 HER2 Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.8 KRAS Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, United States, Average Price ($) , 2018-2033
3.4 Oncology Market, United States, Company Share by Revenue ($m), 2024

Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, United States, Volume (Units), 2018-2033
Table 11: ALK Tests Market, United States, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
Table 19: Oncology Market, United States, Average Price ($), 2018-2033
Table 20: Oncology Market, United States, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Searle Denies Rumour to Acquire 51% Stake in Abbott Laboratories
Table 23: Hanmi Pharma and LG Invests USD5 Million in MEDiC Life Sciences
Table 24: Starboard Value May Acquire Stake in Pfizer for USD1 Billion
Table 25: VION Biosciences Acquires Ansh Labs
Table 26: DERM-JES Holdings Acquires DermTech
Table 27: Breath Diagnostics Raises USD1 Million in Private Placement of Convertible Notes
Table 28: Kiyatec Raises USD0.25 Million in Debt Offering
Table 29: Laboratory Corp of America Holdings Raises USD650 Million in Public Offering of 4.35% Notes Due 2030
Table 30: Laboratory Corp of America Holdings Raised Public Offering of 4.55% Notes Due 2032 for USD500 Million
Table 31: Laboratory Corp of America Holdings Raises USD850 Million in Public Offering of 4.8% Notes Due 2034
Table 32: Illumina Prices USD500 Million in Public Offering of 4.65% Notes Due 2026
Table 33: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, United States, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, United States, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, United States, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, United States, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, United States, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, United States, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, United States, Volume (Units), 2018-2033
Figure 19: Oncology Market, United States, Company Share (%), 2024